Stephanie Kane, DPM
Podiatrist · Loxahatchee, FLNPI 1598285207
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,992 of the $8,737 with a category attached, or 68.6%. 29 manufacturers reported payments, led by Smith+Nephew at 39.9% of the total. Among podiatrist clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 127 payments — averaging $68.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$3K
- Treace Medical Concepts, Inc.$613
- Biotissue Holdings Inc.$437
- Integra Lifesciences Corporation$396
- Medical Device Business Services, Inc.$389
- Abbott$371
- plus $3K from 23 others
What the payments were for
- Travel & lodging$2,03823%
- Food & beverage$5,99269%
- Education$3454%
- Other$3624%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 37 | $3,482 |
| Treace Medical Concepts, Inc. | 16 | $613 |
| Biotissue Holdings Inc. | 3 | $437 |
| Integra Lifesciences Corporation | 3 | $396 |
| Medical Device Business Services, Inc. | 4 | $389 |
| Abbott | 4 | $371 |
| Stryker | 10 | $360 |
| Paratek Pharmaceuticals, Inc. | 5 | $320 |
| Amgen(2 entities) | 6 | $312 |
| Next Science LLC | 1 | $312 |
| Acera Surgical, Inc. | 4 | $312 |
| Johnson & Johnson | 4 | $218 |
| Organogenesis Inc. | 6 | $167 |
| Medshape, Inc. | 1 | $148 |
| Kerecis Limited | 6 | $133 |
| Boston Scientific | 1 | $128 |
| DJO, LLC | 1 | $109 |
| Convatec Inc. | 1 | $107 |
| Solventum Corporation | 1 | $101 |
| Pacira Pharmaceuticals Incorporated | 1 | $98 |
| Trice Medical, Inc. | 1 | $42 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $36 |
| Vertex | 1 | $30 |
| Nevro Corp. | 2 | $29 |
| Bioventus LLC | 2 | $26 |
| Cashflow Solutions, LLC | 1 | $19 |
| Linvatec Corporation | 1 | $19 |
| Tactile Systems Technology Inc | 1 | $17 |
| Flower Orthopedics Coporation | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Oasis$1,419
- ACTICOAT 4" X 4"$1,272
- Versajet$1,272
- Allevyn Gentle Border 10 x 10cm Ctn 10$1,123
- PICO$1,123
- Stravix$831
- Grafix$811
- GRAFIX PL$810
- Prokera$386
- AmnioGraft$386
- AmnioGuard$386
- INTEGRA$362
- SurgX$312
- Xperience$312
- BlastX$312
- Restrata Wound Matrix$284
- KRYSTEXXA$267
- ESPRIT$264
- NUZYRA$247
- COLLAGENASE SANTYL$149
How this compares
$8,737 in reported general payments places this provider in the 90th percentile of 588 podiatrist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 18 | $18,741 |
| Gentamicin Sulfate | 16 | $812 |
| Ketoconazole | 36 | $603 |
| Methylprednisolone | 28 | $167 |
| Mupirocin | 13 | $166 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $46 |
| Ibuprofen | 13 | $45 |
| Meloxicam | 26 | $20 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $36 | $18,74118 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 588 podiatrist providers in Florida.
Other podiatrist in Loxahatchee
- James CottomSarasota$1.8M
- Caroline KiserFleming Island$206K
- Adam PerlerLargo$160K
- Desmond BellJacksonville$125K
- Jeffrey KarrLakeland$101K
- Marie WilliamsAventura$96K
- Todd BrennanTampa$88K
- Robert HooverLake Mary$71K
- Daniel BrandweinPompano Beach$70K
- John TorregrosaMiami$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.